Medication info
Vasoplin Tablet 5/80 mg

Vasoplin Tablet 5/80 mg

Prescription medicationTabletOral
Ingredient · strength
Valsartan›80mg / 1 tabletAmlodipine Besylate›6.94mg / 1 tablet
Manufacturer / importer
Austin Pharmaceutical Co., Ltd.
Appearance
Dark yellow round film-coated tablet
Packaging
28 tablets/box [14 tablets/Alu-Alu × 2]
Approval status
Active

MFDS item code 202001075 · Approved 2020.02.17 · Insurance code 654305350

Summary

Main use
Treatment of essential hypertension not controlled with amlodipine or valsartan monotherapy
Who takes it
Adults · Children
Adult dose
The recommended dose of this medicine is 1 tablet once daily, taken with water without regard to meals. If possible, it is recommended that it be taken at the same time each day (e.g., in the morning). It is recommended that the dose be adjusted using the individual components (amlodipine or valsartan) before starting this medicine. However, if blood pressure is not controlled with monotherapy using the individual components, a direct switch to this medicine may be considered as follows. ․5/80 milligrams: For patients whose blood pressure is not adequately controlled with amlodipine 5 milligrams or valsartan 80 milligrams as monotherapy. ․5/160 milligrams: For patients whose blood pressure is not adequately controlled with amlodipine 5 milligrams or valsartan 160 milligrams as monotherapy. ․10/160 milligrams: For patients whose blood pressure is not adequately controlled with amlodipine 10 milligrams or valsartan 160 milligrams as monotherapy, or with 5/160 milligrams. Patients taking valsartan and amlodipine concomitantly may switch to this medicine (a combination product containing the same amounts of each active ingredient) for convenience. Patients with renal impairment: No dose adjustment is necessary in patients with mild or moderate renal impairment (creatinine clearance 10mL/min or more); however, this medicine should not be administered to patients with severe renal impairment (creatinine clearance less than 10mL/min) or patients on dialysis. Monitoring of potassium levels and creatinine is recommended in patients with moderate renal impairment. Patients with hepatic impairment: In patients with mild or moderate hepatic impairment, the daily dose of valsartan should not exceed 80mg. This medicine should not be administered to patients with severe hepatic impairment, biliary cirrhosis, biliary obstruction, or cholestasis. Older adults aged 65 years and older: Use caution when increasing the dose.
Child dose
Children: Use of this medicine is not recommended in pediatric patients under 18 years of age because its safety and efficacy have not been established.

Ingredients

Manufacturer
Austin Pharmaceutical Co., Ltd.

Efficacy & effects

Treatment of essential hypertension not controlled with amlodipine or valsartan monotherapy

  • Essential hypertension
View approved original text

Patients are in a state of essential hypertension where blood pressure control is not adequate with monotherapy using amlodipine or valsartan. In such cases, using both drugs in combination may help control blood pressure more effectively. Essential hypertension is a condition where maintaining blood pressure within a normal range is important, and appropriate treatment can reduce the risk of cardiovascular diseases and other complications. Therefore, the combination therapy of amlodipine and valsartan is used to manage blood pressure reliably.

How to take

Adult dose

The recommended dose of this medicine is 1 tablet once daily, taken with water without regard to meals. If possible, it is recommended that it be taken at the same time each day (e.g., in the morning). It is recommended that the dose be adjusted using the individual components (amlodipine or valsartan) before starting this medicine. However, if blood pressure is not controlled with monotherapy using the individual components, a direct switch to this medicine may be considered as follows. ․5/80 milligrams: For patients whose blood pressure is not adequately controlled with amlodipine 5 milligrams or valsartan 80 milligrams as monotherapy. ․5/160 milligrams: For patients whose blood pressure is not adequately controlled with amlodipine 5 milligrams or valsartan 160 milligrams as monotherapy. ․10/160 milligrams: For patients whose blood pressure is not adequately controlled with amlodipine 10 milligrams or valsartan 160 milligrams as monotherapy, or with 5/160 milligrams. Patients taking valsartan and amlodipine concomitantly may switch to this medicine (a combination product containing the same amounts of each active ingredient) for convenience. Patients with renal impairment: No dose adjustment is necessary in patients with mild or moderate renal impairment (creatinine clearance 10mL/min or more); however, this medicine should not be administered to patients with severe renal impairment (creatinine clearance less than 10mL/min) or patients on dialysis. Monitoring of potassium levels and creatinine is recommended in patients with moderate renal impairment. Patients with hepatic impairment: In patients with mild or moderate hepatic impairment, the daily dose of valsartan should not exceed 80mg. This medicine should not be administered to patients with severe hepatic impairment, biliary cirrhosis, biliary obstruction, or cholestasis. Older adults aged 65 years and older: Use caution when increasing the dose.

Child dose

Children: Use of this medicine is not recommended in pediatric patients under 18 years of age because its safety and efficacy have not been established.

Precautions

This medication can cause serious harm to the fetus and newborn if taken during the second and third trimesters of pregnancy, and should be discontinued immediately upon confirmation of pregnancy. This medication should not be taken by individuals who have allergies to the ingredients included in this drug or other similar classes of medications, by pregnant or nursing women, by patients with severe renal or hepatic impairment, or by individuals with certain heart conditions. In patients with a deficiency of sodium or fluid, hypotension may occur, so the patient’s condition should be well checked before taking this medication and monitored carefully during treatment. Patients with elevated potassium levels or those taking potassium supplements should have their potassium levels frequently monitored, and caution is also necessary for patients with compromised renal function. This medication can rarely cause a serious allergic reaction called angioedema; if swelling of the face, lips, or tongue occurs, discontinue use immediately. Patients with heart failure or after myocardial infarction should take this medication while periodically checking their renal function and blood pressure, and acute myocardial infarction patients should also be cautious. This medication may interact with other antihypertensive agents or certain medications, so anyone taking other medications should consult a healthcare provider or pharmacist. Dizziness or fatigue may occur during driving or operating machinery, so caution is advised, and elderly patients can take the usual dosage but should be monitored closely. Overdosage of this medication may result in severe hypotension or tachycardia, so it is essential to adhere to the prescribed dosage, and if any abnormal symptoms occur, seek medical attention immediately. Pregnant or nursing individuals are advised to avoid this medication, and it is not recommended for pediatric patients under 18 years old due to insufficient safety and efficacy data.

Side effects

Nasopharyngitis, influenza, hypersensitivity, visual impairment, anxiety, headache, dizziness, drowsiness, positional dizziness, paresthesia, vertigo, tinnitus, tachycardia, palpitations, syncope, orthostatic hypotension, hypotension, cough, pharyngeal and laryngeal pain, diarrhea, nausea, abdominal pain, constipation, dry mouth, rash, erythema, hyperhidrosis, itching, joint swelling, low back pain, arthritis, muscle spasms, lethargy, polyuria, nocturia, erectile dysfunction, edema, localized edema, facial edema, peripheral edema, fatigue, flush, weakness, facial flushing, decreased hemoglobin, decreased hematocrit, neutropenia, thrombocytopenia, hypersensitivity including serum sickness, increased serum potassium, vasculitis, elevated liver function tests, vascular edema, myalgia, renal failure, kidney damage, increased serum creatinine, insomnia, decreased libido, pharyngitis, rhinitis, sinusitis, upper respiratory infection, viral infection, intestinal vascular edema, diplopia, thrombocytopenia, leukopenia, allergic reaction, hyperglycemia, insomnia, mood changes, tremors, sensory loss, taste disturbance, peripheral neuropathy, hypertonic muscles, arrhythmia, bradycardia, atrial fibrillation, ventricular tachycardia, myocardial infarction, vasculitis, dyspnea, rhinitis, vomiting, dyspepsia, pancreatitis, gastritis, gingival hyperplasia, hepatitis, jaundice, alopecia, purpura, skin depigmentation, photosensitivity, vascular edema, urticaria, erythema multiforme, Stevens-Johnson syndrome, myalgia, urinary dysfunction, nocturnal enuresis, gynecomastia, pain, malaise, chest pain, weight loss, weight gain, elevated liver enzymes, chest discomfort, abdominal discomfort, gastroesophageal reflux disease, neck pain, hypercholesterolemia, hypoglycemia, neuropathic irritability, Stevens-Johnson syndrome, chest pain, weight gain, arthralgia, skeletal pain, rhabdomyolysis, gingival hyperplasia, gastritis

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly closed container to protect it from air and moisture and should be kept at room temperature between 1 to 30 degrees Celsius. Proper storage will help maintain the medication's effectiveness for a longer period.

Appearance and packaging

Appearance

Dark yellow round film-coated tablet

Package unit

28 tablets/box [14 tablets/Alu-Alu × 2]

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.